Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1685381 | 0.59 | LTA4H (0.46) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL667777 | 0.58 | PPARG (0.51) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL9242571 | 0.58 | HSD11B1 (0.53) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL11048002 | 0.58 | LTA4H (0.45) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL1676646 | 0.57 | LTA4H (0.53) | RXRARXRBRXRGPPARG | |
| SCHEMBL11317090 | 0.57 | HDAC4 (0.42) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL1053934 | 0.57 | PPARG (0.41) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL30080100 | 0.57 | IDO1 (0.50) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL1070283 | 0.57 | PPARG (0.41) | RXRARXRBRXRGPPARGMRGPRX4 | |
| SCHEMBL30093322 | 0.57 | CA1 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999011129-A1 | ENANTIOMERICALLY ENRICHED COMPOSITIONS AND THEIR PESTICIDAL USE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-03-11 | — | — | WO | disclosed |